相关实验视频

Updated: Jul 23, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

在质母细胞瘤中的化学抗原受体T细胞-当前的概念和有前途的未来

Rebecca Kringel¹, Katrin Lamszus¹, Malte Mohme¹

¹Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

|July 14, 2023

概括

化学抗原受体 (CAR) -T细胞疗法对质母细胞瘤 (GBM),一种致命的脑癌,显示出有前途. 虽然存在瘤透和免疫抑制等挑战,但CAR-T细胞提供了一种可行的治疗方法,具有改善的潜力.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后和有限治疗选择的侵袭性脑瘤.
目前针对GBM的治疗方法的平均存活时间只有15个月,这凸显了迫切需要新的治疗策略.
化学抗原受体 (CAR) -T细胞疗法代表了对GBM的有前途的研究方法.

研究的目的:

评估CAR-T细胞治疗治疗质母细胞瘤的可行性和有效性.
确定与CAR-T细胞疗法相关的挑战和局限性,在像GBM这样的固体瘤的背景下.
探索潜在的目标和未来的方向,以改善在GBM中CAR-T细胞治疗.

主要方法:

卡尔-T细胞是基因工程T细胞,旨在向和消除瘤细胞.
研究已经研究了针对各种GBM抗原的CAR-T细胞,包括IL-13Rα2,EGFRvIII,HER2和EphA2.
临床前和临床研究评估了CAR-T细胞疗法的安全性,疗效和瘤透在GBM模型和患者.

主要成果:

在GBM治疗中,CAR-T细胞疗法已经证明了可行性.
在研究中观察到过渡性反应和可接受的不良反应.
挑战包括限制瘤贩运,免疫抑制瘤微环境,抗原异质性和CAR-T细胞安全问题.

结论:

卡特-T细胞疗法是质母细胞瘤的可行选择,初步显示有前途.
克服与疗效,安全和制造相关的挑战对于更广泛的临床应用至关重要.
在CAR-T细胞设计和传递方面取得进一步的进步,可以将其确立为GBM的关键疗法.

关键词:

在CAR-T细胞中.在GBMGBMGBMGBMGBM 在T细胞,T细胞.质母细胞瘤 (glioblastoma) 是一种质瘤质瘤是一种免疫疗法免疫疗法

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.